Optical detection of gold nanoparticles in a prostate-shaped porcine phantom

Journal of Biomedical Optics

Volumn 18, Issue 7, 2013, Pages

  Grabtchak, Serge ^a,b   Tonkopi, Elena ^b,c   Whelan, William M ^a,d  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

deep tissue imaging; gold nanoparticles; gold nanorods; interstitial fiber optic diagnostics; localized inclusion; optical contrast agents; porcine phantom; prostate cancer; radiance spectroscopy; spectro angular mapping

Indexed keywords

DEEP TISSUE IMAGING; GOLD NANOPARTICLES; GOLD NANOROD; OPTICAL CONTRAST AGENT; PORCINE PHANTOM; PROSTATE CANCERS;

BINDING SITES; DETECTORS; DISEASES; METAL NANOPARTICLES; NANORODS; PLASMONS; SOURCE SEPARATION; TISSUE; UROLOGY;

GOLD;

GOLD; METAL NANOPARTICLE; NANOTUBE;

ANATOMY AND HISTOLOGY; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DEVICES; FIBER OPTICS; FLUORESCENCE IMAGING; IMAGE PROCESSING; IMAGE QUALITY; MALE; MUSCLE; PROCEDURES; PROSTATE; SPECTROSCOPY; SWINE; ARTICLE; EQUIPMENT; HISTOLOGY; METHODOLOGY;

ANIMALS; FIBER OPTIC TECHNOLOGY; GOLD; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METAL NANOPARTICLES; MODELS, BIOLOGICAL; MUSCLES; NANOTUBES; OPTICAL IMAGING; PHANTOMS, IMAGING; PROSTATE; SPECTRUM ANALYSIS; SWINE;

EID: 84888767553     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.18.7.077005     Document Type: Article

References (35)

1. L. R. Hirsch et al. "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance," Proc. NATL Acad. Sci. U.S.A. 100(23), 13549-13554 (2003). (Pubitemid 37444779)
2. E. B. Dickerson et al., "Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice," Cancer Lett. 269(1), 57-66 (2008).
3. K. Sokolov et al. "Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles," Cancer Res. 63(9), 1999-2004 (2003). (Pubitemid 36538596)
4. R. Popovtzer et al., "Targeted gold nanoparticles enable molecular CT imaging of cancer," Nano Lett. 8(12), 4593-4596 (2008).
5. X. H. Huang et al., "Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods," J. Amer. Chem. Soc. 128(6), 2115-2120 (2006).
6. D. B. Chithrani et al., "Gold nanoparticles as radiation sensitizers in cancer therapy," Radiat. Res. 173(6), 719-728 (2010).
7. G. Han, P. Ghosh, and V. M. Rotello, "Functionalized gold nanoparticles for drug delivery," Nanomedicine 2(1), 113-123 (2007). (Pubitemid 46845782)
8. S. D. Brown et al., "Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin," J. Am. Chem. Soc. 132(13), 4678-4684 (2010).
9. D. Pissuwan, T. Niidome, and M. B. Cortie, "The forthcoming applications of gold nanoparticles in drug and gene delivery systems," J. Controll. Rel. 149(1), 65-71 (2011).
10. W. P. Faulk and G. M. Taylor, "Immunocolloid method for electron microscope," Immunochemistry 8(11), 1081 (1971).
11. T. Reuveni et al., "Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study," Int. J. Nanomed. 6 2859-2864 (2011).
12. J. F. Hainfeld et al., "Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions," Br. J. Radiol. 84(1002), 526-533 (2011).
13. J. V. Frangioni, "New technologies for human cancer imaging," J. Clin. Oncol. 26(24), 4012-4021 (2008).
14. P. K. Jain et al., "Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine," J. Phys. Chem. B 110(14), 7238-7248 (2006).
15. W. Qian et al., "Dark-field light scattering imaging of living cancer cell component from birth through division using bioconjugated gold nanoprobes," J. Biomed. Opt. 15(4), 046025 (2010).
16. S. R. Arridge, "Optical tomography in medical imaging," Inverse Problems 15(2), R41-R93 (1999).
17. T. Durduran et al., "Diffuse optics for tissue monitoring and tomography," Rep. Prog. Phys. 73(7), 76701-76743 (2010).
18. S. Krishnan, P. Diagaradjane, and S. H. Cho, "Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy," Int. J. Hyperthermia 26(8), 775-789 (2010).
19. J. A. Schwartz et al., "Selective nanoparticle-directed ablation of the canine prostate," Lasers Surg. Med. 43(3), 213-220 (2011).
20. X. J. Zhang et al., "Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles," Clin. Invest. Med. 31(3), E160-E167 (2008).
21. N. Chanda et al., "Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-(198)AuNP nanoconstruct in prostate tumor-bearing mice," Nanomed.-Nanotechnol. Biol. Med. 6(2), 201-209 (2010).
22. S. Grabtchak, T. J. Palmer, and W. M. Whelan, "Detection of localized inclusions of gold nanoparticles in Intralipid-1% by point-radiance spectroscopy," J. Biomed. Opt. 16(7), 077003 (2011).
23. S. Grabtchak, T. J. Palmer, andW. Whelan, "Radiance spectroscopy tool box for characterizing Au nanoparticles in tissue mimicking phantoms as applied to prostate," J. Cancer Sci. Ther. S1, 008 (2011).
24. S. Grabtchak et al., "Experimental spectro-angular mapping of light distribution in Intalipid-1%," J. Biomed. Opt. 17(6), 067007 (2012).
25. S. Prahl, "Tabulated Molar Extinction Coefficient for Hemoglobin in Water," Oregon Medical Laser Center, Oregon, (4 March 1998).
26. S. Grabtchak et al., "Radiance detection of non-scattering inclusions in turbid media," Biomed. Opt. Express 3(11), 3001-3011 (2012).
27. S. L. Chowning et al., "A preliminary analysis and model of prostate injection distributions," Prostate 66(4), 344-357 (2006). (Pubitemid 43346945)
28. J. Gossner, "Computed tomography of the prostate-a review," Intern. J. Radiol. 14(1), (2012).
29. P. M. Smith-Jones et al., "In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostatespecific membrane antigen," Cancer Res. 60(18), 5237-5243 (2000).
30. G. N. Collins et al., "The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ration in clinical practice," J. Urol. 157(5), 1744-1747 (1997). (Pubitemid 27171766)
31. S. F. Matin et al., "Office cystoscopy and transrectal ultrasound-guided prostate biopsies pose minimal risk: prospective evaluation of 921 procedures," Urology 73(6), 1175-1178 (2009).
32. G. F. Paciotti et al., "Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery," Drug Deliv. 11(3), 169-183 (2004). (Pubitemid 38720414)
33. D. Dolmans, D. Fukumura, and R. K. Jain, "Photodynamic therapy for cancer," Nat. Rev. Cancer 3(5), 380-387 (2003). (Pubitemid 37328858)
34. S. C. Feng, F. A. Zeng, and B. Chance, "Photon migration in the presence of a single defect-a perturbation analysis," Appl. Opt. 34(19), 3826-3837 (1995).
35. S. B. Colak et al., "Tomographic image reconstruction from optical projections in light-diffusing media," Appl. Opt. 36(1), 180-213 (1997). (Pubitemid 127615563)